Pevion Biotech AG Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
3/8/2012 11:17:31 AM
More...
|
Pevion Biotech AG's Therapeutic Candida Vaccine Generates Functional B Cell Memory in all Vaccinees
1/17/2012 10:05:59 AM
More...
|
Pevion Biotech AG's Therapeutic Candida Vaccine Shows Robust Systemic and Mucosal Immunogenicity, While Epidemiological Survey Confirms Excellent Market Potential
10/11/2011 10:48:48 AM
More...
|
Pevion Biotech AG Grants CSL Limited (CMXHF.PK) Option Right to its Therapeutic Candida Vaccine
9/1/2011 6:22:54 AM
More...
|
Pevion Biotech Ltd. Appoints New CEO and Secures CHF 10 Million ($9.9 Million) Financing
9/7/2010 6:19:02 AM
More...
|
Pevion Biotech Ltd. and CEVEC Pharma Sign Exclusive License Option Agreement
5/26/2010 11:31:57 AM
More...
|
Pevion Biotech Ltd.'s PEV7 Vulvovaginal Candidiasis Vaccine Enters Phase I
3/22/2010 9:32:23 AM
More...
|
Positive Phase I Trial Results for Pevion Biotech Ltd.'s and Bio Life Science's Breast Cancer Vaccine
6/22/2009 12:23:24 PM
More...
|
Pevion Biotech Ltd. Appoints New CEO
1/12/2009 7:35:40 AM
More...
|
MYMETICS Corporation Acquires Preventive Malaria Vaccine From Pevion Biotech Ltd.
5/19/2008 8:39:32 AM
More...
|
|